Benzofurylpiperazine serotonin agonists
AssigneeEli Lilly and Company
InventorsKarin Briner, Timothy Paul Burkholder, Mark Louis Heiman, David Lloyd Garver Nelson
Life of this patent
Estimating the term…
Abstract
The present invention provides serotonergic benzofurans of Formula I: where R is methyl or ethyl, or pharmaceutically acceptable acid addition salts thereof.
Claims18
A compound of formula
- where R is methyl or ethyl, or a pharmaceutically acceptable acid addition salt thereof.
A pharmaceutical formulation which comprises, in association with a pharmaceutically acceptable carrier, diluent or excipient, a compound of Formula I:
- where R is methyl or ethyl, or a pharmaceutically acceptable acid addition salt thereof.
A method for the treatment of obesity in mammals, comprising administering to mammal in need of such treatment an effective amount of a compound of Formula I:
- where R is methyl or ethyl, or a pharmaceutically acceptable acid addition salt thereof.
A method for the treatment of obsessive compulsive disorder in mammals, comprising administering to a mammal in need of such treatment a pharmaceutically effective amount of a compound of Formula I:
- where R is methyl or ethyl, or a pharmaceutically acceptable acid addition salt thereof.
A method for the treatment of depression in mammals, comprising administering to a mammal in need of such treatment a pharmaceutically effective amount of a compound of Formula I:
- where R is methyl or ethyl, or a pharmaceutically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.